Pharmacological interventions aimed at increasing HDL-C concentrations (fibrates, niacin, statins, inhibitors of the cholesteryl ester transfer protein –CETP–) have failed to reduce the incidence of cardiovascular disease (CVD) [1,3]. Here, CETP is linked to cardiovascular disorder.